4Cali BR,Thomas NE,Anderson JA,et al.Effect of phamachtherapy on rate of decline of lung function in chronic obstructive pulmonary disease Result from the TORCH study[J].Am J Respir Crit Care Med J,2008,178(1):332-338. 被引量：1
5Keam SJ,Keating GM,Tiotropium bromide.A review of its use as maint enance therapy in patients with COPD[J].Treat Respir Med,2004,3(4):247-268. 被引量：1
6Gil Aldea I,Azanza JR,Palacios E,et aLTiotropium[J].Rev Med Univ Navarra,2003,47(3):49-52. 被引量：1
7Calery P M,Towse I,Lee A.The timing of daose and pattern of bronchodilation of tiotropium(TIO)in stable COPD[J].Eur Respir J,2000,16(Suppl 31):56S. 被引量：1
8Levin DC,Little KS,Laughlin KR,et al.Addition of anticholin ergic solution prolongs bronch odilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease[J].Am J Med,1996,100(IA):40S-48S. 被引量：1
9Currie GP,Rossiter C,Miles SA,et al.Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease[J].Pulm Pharmacol Ther,2006;19:112-9. 被引量：1
10Maltais F,Hamilton A,Marciniuk D,et al.Improvements in symptomlimited exercise performance over 8 h with once daily tiotropium in patients with COPD[J].Chest,2005 ;128:1168-78. 被引量：1
